🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1/2, open-label, multicenter study to determine the efficac...
Status
Active Not Recruiting
Location
Local Institution - 0006
Start Date
2017-11-27
Trial ID
NCT03331198
The goal of this study is to evaluate the safety and efficacy of CD19 CAR T...
Status
Not Yet Recruiting
Location
Henan Province Engineering Technology Research Center of Immunological Precision Medicine and Artificial Intelligence Application, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, China
Start Date
2025-09-30
Trial ID
NCT07161193
Treatments Being Tested
The main purpose of this study is to explore the sequential therapeutic eff...
Status
Unknown
Location
Southwest Hospital of Third Millitary Medical University
Start Date
2016-03
Trial ID
NCT02737085
Treatments Being Tested
This research study is studying the combination of anakinra and axicabtagen...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2020-10-01
Trial ID
NCT04150913
Treatments Being Tested
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Terminated
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2010-03-08
Trial ID
NCT01022138
Treatments Being Tested
This research study is evaluating the safety and efficacy of a combination ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2020-07-20
Trial ID
NCT04290546
Treatments Being Tested
This is a study to investigate the efficacy and safety of an infusion of IO...
Status
Recruiting
Location
The Angeles Clinic and Research Institute
Start Date
2022-07-20
Trial ID
NCT05361174
Treatments Being Tested
DELTA-2 is a phase 1 clinical trial to evaluate the safety, feasibility, an...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-08
Trial ID
NCT05393635
Treatments Being Tested
This is a single arm,open-label, non-randomized phase 2 study to determine ...
Status
Unknown
Location
Shanghai Mengchao Cancer Hospital
Start Date
2021-06-04
Trial ID
NCT05472610
Treatments Being Tested